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Somava Stout, MD,3 Peggy A. Honoré, DHA4IntroductionPopulation health outcomes are distributed dispro-portionately among the many subpopulationscomposing an aggregated total population.1
Evidence-informed program interventions are most
likely to be applied effectively when target subpopula-
tions are deﬁned with optimal precision.2 Comprehen-
sive reviews of current approaches for deﬁning and
measuring population health ﬁnd that they are typically
composed of lists of county-level indicators, which lack
the granular data to measure subpopulation disparities
and provide little or no synergy for priority setting or the
formulation of intervention strategies at the local level.3,4
We use Florida mortality data to demonstrate a new
approach to subpopulation analytics that stages multiple
sources of event-level data in a conformed data ware-
house, with an online analytic processing interface and
customized algorithms providing ﬂexible and powerful
analytic capabilities.
Methods
We used individual mortality data from the Florida Department of
Heath for every death during the 3 years of 2008–2010, analyzed in
2014. Death (mortality) was the outcome of interest and it was
characterized by the following variables:1. gender (male, female);
2. race (black, white, other);
3. age band (0–17, 18–44, 45–64, Z65 years);
4. cause of death (National Center for Health Statistics X 113);
5. year (X 3); and
6. county (X 67).
This combination of variables yielded 545,112 subpopulations
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grew to 7.3 million. To simplify the demonstration, we show only
the subpopulations from a single Florida county (Orange) that
have ten or more deaths and compare blacks and whites for the
combined 3-year period.
Four comparative measures were used to rank-order the
subpopulations:1.vie
mmnumber of deaths;
2. death rate per 100,000 population;
3. Z-score; and
4. difference between black and white Z-scores (racial disparity).
The Z-score normalizes the mortality rates to a common
standard across the range of causes of death and age bands by
computing the state-based mean rate and subpopulation SD for
each age-banded cause of death, identifying those subpopulations
at the outer boundary of the population distribution.
We show only the top 25 subpopulations ranked by each single
comparative measure.
Results
Each of the comparative measures produced a very different
view of the Orange County subpopulations. Those furthest
from the state mean death rates (Z-score) were mostly
black, homicide by ﬁrearms; neoplasms of the prostate,
uterus, breast, colon; HIV; and diabetes (Table 1). The
subpopulations sorted by the size of the racial disparity, by
contrast, were more equally divided by race. The white
causes of death with disparities favoring blacks included
melanoma; accidental poisoning and exposure to toxic
substances (including drug-related deaths); and suicides
(Table 2). Only a few of the subpopulations with the highest
death counts appeared in the top 25 for either the Z-score or
racial disparity rankings. Fixed groups of county-level
indicators and their static logic models are incapable of
analyzing the complex interactions of determinants and
active agents from which local health status emerges.5
Discussion
As demonstrated by our simple example using only a
single data source and outcome, understanding com-
munity health status requires the ability to deﬁne and
analyze subpopulations in multiple ways and for manyr Inc. This is an
ons.org/licenses/by-nc-nd/4.0/).
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Table 1. Top 25 Subpopulations by Z-Score and Total Deaths (Black and White)
Cause of death Gender Race Age Deaths Rate Z-score
Ranked by Z-score (black and white)
Assault (homicide) by discharge of ﬁrearms Male Black 18–44 86 64.88 2.40
Assault (homicide) by discharge of ﬁrearms Male Black 45–64 11 17.64 2.37
Malignant neoplasm of prostate Male Black 45–64 12 19.24 2.23
Malignant neoplasms of corpus uteri and uterus, part
unspeciﬁed
Female Black Z65 16 59.39 2.20
Malignant neoplasm of breast Female Black 18–44 15 10.97 2.18
Certain conditions originating in the perinatal period Male Black 18–44 11 8.3 2.13
Human immunodeﬁciency virus (HIV) disease Male Black 45–64 39 62.53 2.11
Diabetes mellitus Male Black 18–44 11 8.3 2.1
Atherosclerotic cardiovascular disease, so described Male Black 45–64 30 48.1 2.02
Other diseases of arteries, arterioles, and capillaries Female Black Z65 12 44.55 2.01
Malignant neoplasm of prostate Male Black Z65 45 235.53 1.94
Certain conditions originating in the perinatal period Male Black 0–17 51 47.62 1.86
Essential (primary) hypertension and hypertensive renal disease Female Black Z65 26 96.51 1.81
Cerebrovascular diseases Male Black 45–64 30 48.1 1.79
Renal failure Female Black 45–64 17 24.77 1.79
Malignant neoplasms of colon, rectum, and anus Male Black 45–64 24 38.48 1.76
Diabetes mellitus Female Black 45–64 36 52.46 1.75
Congenital malformations, deformations, and chromosomal
abnormalities
Female Black 0–17 14 13.74 1.73
Certain other intestinal infections Male White Z65 29 25.91 1.68
Human immunodeﬁciency virus (HIV) disease Male Black 18–44 26 19.61 1.67
Hypertensive heart disease Male Black 45–64 19 30.46 1.66
Hypertensive heart disease Female Black Z65 26 96.51 1.66
Malignant neoplasm of ovary Female White Z65 73 49.75 1.66
Malignant neoplasm of esophagus Male White Z65 56 50.04 1.59
All other and unspeciﬁed malignant neoplasms Male White 18–44 17 3.99 1.54
Ranked by number of deaths (black)
All other diseases Female Black Z65 139 515.98 0.55
All other forms of chronic ischemic heart disease Female Black Z65 108 400.91 0.04
Assault (homicide) by discharge of ﬁrearms Male Black 18–44 86 64.88 2.40
Cerebrovascular diseases Female Black Z65 70 259.85 0.61
Malignant neoplasms of trachea, bronchus, and lung Male Black Z65 64 334.97 0.66
All other forms of chronic ischemic heart disease Male Black Z65 62 324.51 –0.31
Certain conditions originating in the perinatal period Male Black 0–17 51 47.62 1.86
Cerebrovascular diseases Male Black Z65 51 266.93 0.68
Diabetes mellitus Female Black Z65 49 181.89 1.09
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Table 1. Top 25 Subpopulations by Z-Score and Total Deaths (Black and White) (continued)
Cause of death Gender Race Age Deaths Rate Z-score
Alzheimer disease Female Black Z65 48 178.18 0.62
All other forms of heart disease Female Black Z65 47 174.47 0.11
Malignant neoplasm of prostate Male Black Z65 45 235.53 1.94
Diabetes mellitus Male Black Z65 41 214.59 1.52
Certain conditions originating in the perinatal period Female Black 0–17 40 39.25 1.42
All other forms of chronic ischemic heart disease Male Black 45–64 40 64.13 1.15
Other chronic lower respiratory diseases Male Black Z65 40 209.36 –0.10
Malignant neoplasms of trachea, bronchus, and lung Female Black Z65 40 148.48 –0.63
Human immunodeﬁciency virus (HIV) disease Male Black 45–64 39 62.53 2.11
All other forms of heart disease Male Black Z65 38 198.89 0.38
Malignant neoplasms of trachea, bronchus, and lung Male Black 45–64 37 59.32 0.24
Diabetes mellitus Female Black 45–64 36 52.46 1.75
Renal failure Female Black Z65 34 126.21 1.20
Acute myocardial infarction Female Black Z65 34 126.21 –0.52
Other chronic lower respiratory diseases Female Black Z65 32 118.79 –0.77
Malignant neoplasm of breast Female Black 45–64 31 45.17 1.46
Ranked by number of deaths (white)
All other diseases Female White Z65 857 584.10 0.87
All other forms of chronic ischemic heart disease Male White Z65 646 577.25 0.86
All other forms of chronic ischemic heart disease Female White Z65 625 425.98 0.16
Other chronic lower respiratory diseases Female White Z65 431 293.75 0.53
Malignant neoplasms of trachea, bronchus, and lung Male White Z65 407 363.69 0.86
Cerebrovascular diseases Female White Z65 383 261.04 0.62
Other chronic lower respiratory diseases Male White Z65 368 328.84 0.79
Malignant neoplasms of trachea, bronchus, and lung Female White Z65 360 245.36 0.04
Alzheimer disease Female White Z65 317 216.06 1.08
All other forms of heart disease Female White Z65 292 199.02 0.38
Acute myocardial infarction Female White Z65 245 166.98 –0.08
All other forms of heart disease Male White Z65 240 214.46 0.55
Acute myocardial infarction Male White Z65 240 214.46 0.43
Cerebrovascular diseases Male White Z65 198 176.93 –0.19
Symptoms, signs and abnormal clinical and laboratory ﬁndings,
not elsewhere classiﬁed
Female White Z65 192 130.86 0.22
Malignant neoplasms of trachea, bronchus and lung Male White 45–64 181 64.02 0.40
Diabetes mellitus Female White Z65 179 122.00 0.31
Malignant neoplasm of prostate Male White Z65 178 159.06 1.13
Malignant neoplasm of breast Female White Z65 170 115.87 1.41
(continued on next page)
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Table 1. Top 25 Subpopulations by Z-Score and Total Deaths (Black and White) (continued)
Cause of death Gender Race Age Deaths Rate Z-score
All other forms of chronic ischemic heart disease Male White 45–64 165 58.36 0.92
Accidental poisoning and exposure to noxious substances Male White 18–44 156 36.64 1.32
Diabetes mellitus Male White Z65 156 139.40 0.54
Alzheimer disease Male White Z65 144 128.67 0.02
Motor vehicle accidents Male White 18–44 130 30.54 1.34
Heart failure Female White Z65 130 88.60 0.87
Table 2. Top 25 Subpopulations by Racial Disparity
Selected race Opposite race
Gender Race Age Cause of death Z difference Deaths Rate Z-score Deaths Rate Z-score
Male White 45–64 Falls 2.65 24 8.49 1.48 0 –1.17
Male White Z65 Malignant neoplasms
of kidney and renal
pelvis
2.59 38 33.96 1.32 0 –1.27
Male White Z65 Malignant melanoma
of skin
2.45 27 24.13 1.23 0 –1.22
Male Black 45–64 Assault (homicide) by
discharge of ﬁrearms
2.43 11 17.64 2.37 5 1.77 –0.06
Male White Z65 Intentional self-harm
(suicide) by discharge
of ﬁrearms
2.32 31 27.7 1.38 0 –0.94
Male Black 18–44 Assault (homicide) by
discharge of ﬁrearms
2.29 86 64.88 2.40 43 10.10 0.11
Male White 45–64 Malignant melanoma
of skin
2.25 21 7.43 1.18 0 –1.07
Male White 18–44 Accidental poisoning
and exposure to
noxious substances
2.16 156 36.64 1.32 7 5.28 –0.84
Male Black 18–44 Diabetes mellitus 2.15 11 8.3 2.1 8 1.88 –0.05
Male White 45–64 Other and
unspeciﬁed
nontransport
accidents and their
sequelae
2.13 14 4.95 0.77 0 –1.36
Male Black 45–64 Human
immunodeﬁciency
virus (HIV) disease
2.07 39 62.53 2.11 37 13.09 0.04
Male White Z65 Certain other
intestinal infections
2.03 29 25.91 1.68 2 10.47 –0.35
Female Black 45–64 Diabetes mellitus 2.02 36 52.46 1.75 50 17.10 –0.27
Male Black 45–64 Cerebrovascular
diseases
1.99 30 48.1 1.79 43 15.21 –0.20
Male Black 18–44 Certain conditions
originating in the
perinatal period
1.95 11 8.3 2.13 9 2.11 0.18
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Table 2. Top 25 Subpopulations by Racial Disparity (continued)
Selected race Opposite race
Gender Race Age Cause of death Z difference Deaths Rate Z-score Deaths Rate Z-score
Male White Z65 Malignant neoplasms
of meninges, brain,
and other parts of
central nervous
system
1.93 27 24.13 1.04 1 5.23 –0.89
Male Black 45–64 Hypertensive heart
disease
1.93 19 30.46 1.66 26 9.20 –0.27
Female Black 45–64 Renal failure 1.91 17 24.77 1.79 17 5.82 –0.12
Female Black 18–44 Human
immunodeﬁciency
virus (HIV) disease
1.86 25 18.29 1.51 11 2.73 –0.35
Female White Z65 Atherosclerosis 1.79 30 20.45 0.65 1 3.71 –1.14
Female Black Z65 Other diseases of
arteries, arterioles,
and capillaries
1.76 12 44.55 2.01 25 17.04 0.25
Female Black 0–17 Congenital
malformations,
deformations, and
chromosomal
abnormalities
1.75 14 13.74 1.73 13 5.79 –0.02
Male White Z65 Parkinson disease 1.72 98 87.57 1.34 6 31.4 –0.38
Male Black 0–17 Certain conditions
originating in the
perinatal period
1.72 51 47.62 1.86 35 14.87 0.14
Male Black 45–64 Malignant neoplasm
of prostate
1.70 12 19.24 2.23 20 7.07 0.53
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prioritizing criteria will signiﬁcantly change the rankings
of community health outcomes.6 Existing sources of
publicly available granular de-identiﬁed data and power-
ful information technology enable hundreds of millions
of subpopulations to be deﬁned and analyzed for multi-
ple outcomes, such as deaths (as in our demonstration),
avoidable hospitalizations, inpatient and ambulatory
surgical complications, readmissions, newly diagnosed
cancers, emergency room visits, and many others.
Because of the event-level nature of this data, integration
with clinical data from electronic health records and
other treatment subpopulations is feasible. Subpopula-
tion analytics that is deployed and evolved on a national
scale will inform population health improvement in the
same way that genomics and metabolomics are inform-
ing clinical disease management.This methods development and demonstration study were
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